Abstract:

Objective　To explore the effect of electromyographic biofeedback in the treatment of patients suffering from hemiplegia during acute stage of cerebral infarction. Methods　One hundred patients suffering from hemiplegia during acute stage of cerebral infarction treated at Jieyang People's Hospital from July 2021 to June 2023 were selected for the randomized controlled trial, and were divided into an observation group and a control group by the random number table method, with 50 cases in each group. At last, there were 47 cases in the observation group, including 26 males and 21 females who were (65.40±10.45) years old; there were 50 cases in the control group, including 29 males and 21 females who were (68.40±13.78) years old. Both groups routinely took neurological drugs and early rehabilitation; in addition, the observation group took electromyographic biofeedback treatment. The scores of Munual Muscle Testing (MMT), Brunnstrom's neurophysiological assessment, and Barthel index were compared between the two groups before and after the treatment. Wilcoxon non-parameter test was applied. Results　The scores of MMT and Brunnstrom's neurophysiological assessment of the upper and lower limbs and Barthel index were higher after than before the treatment in both groups (all P<0.05); after the treatment, the scores of MMT of the lower limbs [3.00 (2.00, 4.00) vs. 2.00 (2.00, 3.00)], Brunnstrom's neurophysiological assessment [upper limbs: 2.00 (2.00, 3.00) vs. 2.00 (1.00, 2.00); lower limbs: 3.00 (2.00, 4.00) vs. 2.00 (2.00, 3.00)], and Barthel index [55.00 (50.00, 65.00) vs. 35.00 (15.00, 55.00)] in the observation group were better than those in the control group (all P<0.05). Conclusion　Electromyographic biofeedback for patients suffering from hemiplegia during acute stage of cerebral infarction can promote their recovery of the hemiplegic limbs' function, so it is worth being clinically generalized.

Key words:

Stroke, Rehabilitation, Biofeedback

摘要：

目的　探讨肌电生物反馈治疗脑梗死急性期偏瘫患者的效果。方法　选取2021年7月至2023年6月在揭阳市人民医院治疗的脑梗死急性期偏瘫患者100例进行随机对照试验。采用随机数字表法将其分为观察组与对照组，各50例；最终，观察组47例，男26例，女21例，年龄（65.40±10.45）岁；对照组50例，男29例，女21例，年龄（68.40±13.78）岁。均接受常规神经内科药物治疗，对照组采用早期常规康复治疗，观察组采用早期常规康复治疗和肌电生物反馈治疗。对比治疗前后两组患者上下肢肌力、日常生活活动能力和运动功能。采用Wilcoxon非参数检验。结果　治疗后，两组患者上下肢肌力、Brunnstrom分期和改良Barthel指数均有提高（均P<0.05），且观察组下肢肌力［3.00（2.00，4.00）比2.00（2.00，3.00）］、Brunnstrom分期［上肢2.00（2.00，3.00）比2.00（1.00，2.00），下肢3.00（2.00，4.00）比2.00（2.00，3.00）］和改良Barthel指数［55.00（50.00，65.00）比35.00（15.00，55.00）］均优于对照组（均P<0.05）。结论　采用肌电生物反馈治疗脑梗死急性期偏瘫肢体患者能更好地促进患者偏瘫肢体功能的康复，值得临床推广应用。

关键词:

脑梗死, 康复, 生物反馈